Get the Stockscreener App
2.68
0.00%
0.00
After Hours:
2.70
0.02
+0.75%
Oncology Institute Inc stock is traded at $2.68, with a volume of 1.21M.
It is up +0.00% in the last 24 hours and down -35.89% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$2.68
Open:
$2.66
24h Volume:
1.21M
Relative Volume:
0.54
Market Cap:
$263.66M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-3.3924
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
-1.83%
1M Performance:
-35.89%
6M Performance:
-37.38%
1Y Performance:
+168.00%
1-Day Range:
$2.63
$2.87
1-Week Range:
$2.42
$2.87
52-Week Range:
$0.6015
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, FMS, UHS, ENSG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
2.68 | 263.66M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
502.05 | 113.54B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
193.04 | 16.96B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 13.85B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
212.78 | 13.31B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
203.93 | 11.58B | 4.11B | 239.98M | 193.10M | 4.12 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Critical Analysis: Alignment Healthcare (NASDAQ:ALHC) versus Oncology Institute (NASDAQ:TOI) - Defense World
IPO Launch: What is The Oncology Institute Inc Equity Warrants revenue forecast2025 Short Interest & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Contrasting Pheton (NASDAQ:PTHL) and Oncology Institute (NASDAQ:TOI) - Defense World
Insider Trends: How do insiders feel about The Oncology Institute Inc Equity WarrantWeekly Profit Recap & AI Enhanced Trading Signals - baoquankhu1.vn
Resistance Check: What are the risks of holding The Oncology Institute IncWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn
Aug Wrap: Should you avoid The Oncology Institute Inc stock right nowJuly 2025 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 26% Hiding - simplywall.st
Big Picture: Can The Oncology Institute Inc ride the EV wave2025 Retail Activity & Real-Time Volume Spike Alerts - baoquankhu1.vn
Resistance Check: What are analysts price targets for The Oncology Institute IncSwing Trade & Long-Term Growth Stock Strategies - baoquankhu1.vn
Portfolio Shifts: Is The Oncology Institute Inc showing insider buyingQuarterly Earnings Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Aug Summary: Is Installed Building Products Inc undervalued by DCF analysisPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Insider Trends: Will The Oncology Institute Inc outperform during market ralliesOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
New Illinois cancer institute joins ICON network to widen trial access - Stock Titan
Reviewing Oncology Institute (NASDAQ:TOI) & Zicix (OTCMKTS:ZICXD) - Defense World
Trend Review: Is The Oncology Institute Inc impacted by rising rates2025 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
Aug Intraday: Can The Oncology Institute Inc continue delivering strong returnsWeekly Profit Report & AI Enhanced Execution Alerts - baoquankhu1.vn
Insider Sell: Is DHI Group Inc still a buy after recent gainsAnalyst Upgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Is The Oncology Institute Inc showing insider buyingJuly 2025 Final Week & Short-Term High Return Strategies - baoquankhu1.vn
Profit Recap: Does The Oncology Institute Inc have strong fundamentalsWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Will The Oncology Institute Inc. stock gain from strong economyTrading Volume Surges & Double Digit Profit Strategies - Bollywood Helpline
Why The Oncology Institute Inc. Equity Warrant stock could see breakout soon2025 Market Sentiment & AI Forecast for Swing Trade Picks - Bollywood Helpline
Market Overview: Is LG E Natural Inc Preferred Security exposed to political riskQuarterly Trade Review & Smart Investment Allocation Tips - baoquankhu1.vn
ETF Watch: Is The Oncology Institute Inc Equity Warrant a potential multi baggerJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - baoquankhu1.vn
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
The Oncology Institute Announces Leadership Promotions - Futubull
Market Recap: Will The Oncology Institute Inc stock maintain momentum in 2025 - Bộ Nội Vụ
The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue - MSN
The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook - TradingView
The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook - manilatimes.net
Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions? - simplywall.st
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care - GlobeNewswire Inc.
Is Oncology Institute (TOI) Quietly Rewiring Its Edge Around AI Talent And Boardroom Financial Discipline? - Yahoo Finance
The Oncology Institute Announces Promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer - Quiver Quantitative
Is The Oncology Institute Inc. stock a buy before product launchesMarket Performance Report & Risk Controlled Swing Trade Alerts - Улправда
Will The Oncology Institute Inc. stock attract more institutional investorsJuly 2025 Update & Daily Chart Pattern Signal Reports - Улправда
Can The Oncology Institute Inc. stock deliver surprise earnings beatMarket Performance Summary & Expert Verified Stock Movement Alerts - Улправда
Will The Oncology Institute Inc. Equity Warrant stock deliver consistent dividendsEarnings Performance Report & Weekly Top Gainers Trade List - Улправда
Can The Oncology Institute Inc. Equity Warrant stock rebound after recent weakness2025 Fundamental Recap & Target Return Focused Picks - Улправда
How The Oncology Institute Inc. Equity Warrant stock trades during market volatilityIndex Update & Weekly Setup with ROI Potential - Улправда
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard - The Globe and Mail
Oncology Institute Adds Independent Director and Audit Chair - The Globe and Mail
For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move - simplywall.st
The Oncology Institute Announces Addition of Board Member Mark Stolper - marketscreener.com
Can The Oncology Institute Inc. Equity Warrant stock sustain free cash flow growth2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Will The Oncology Institute Inc. Equity Warrant stock reach Wall Street targetsJuly 2025 Recap & Expert Approved Trade Ideas - Улправда
Will The Oncology Institute Inc. stock gain from government policiesMarket Growth Report & Momentum Based Trading Signals - Улправда
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):